Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other financing activities (2019 - 2025)

Bioadaptives' Other financing activities history spans 6 years, with the latest figure at $115000.0 for Q2 2025.

  • For Q2 2025, Other financing activities changed N/A year-over-year to $115000.0; the TTM value through Jun 2025 reached $47500.0, changed N/A, while the annual FY2023 figure was -$2500.0, N/A changed from the prior year.
  • Other financing activities for Q2 2025 was $115000.0 at Bioadaptives, up from $90000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $115000.0 in Q2 2025 and bottomed at -$167500.0 in Q4 2023.
  • The 4-year median for Other financing activities is $42500.0 (2021), against an average of $15694.5.
  • The largest annual shift saw Other financing activities skyrocketed 630.71% in 2021 before it plummeted 86.67% in 2022.
  • A 4-year view of Other financing activities shows it stood at -$28333.0 in 2021, then surged by 135.29% to $10000.0 in 2022, then plummeted by 1775.0% to -$167500.0 in 2023, then skyrocketed by 168.66% to $115000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Other financing activities are $115000.0 (Q2 2025), $90000.0 (Q1 2025), and -$167500.0 (Q4 2023).